{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_24", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-26 16:25:28", "close_timestamp": 1637943928417, "created": "26/11/2021 16:25:20", "department": "Occupational Psychology", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-26", "gender": "female", "id": "556957f0-4eeb-4b86-a964-9b7ab706b9b7", "open_date_time": "2021-10-26 16:15:54", "open_timestamp": 1637943354781, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "An experiment looking into, FDA-approved, Ivermectin, and effects on covid cells. Effective after 48hs.", "task_condition": "text", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 573636, "what": "how effective ivermectin is in reducing all the numbers of RNA cells after 48hrs and even has an effect after 24hr, the drug is already commonly used and easily available, FDA approved as anti-parasitic ", "when_happened": "few_month_ago", "where_location": "in australia melbourne ", "who": "Ivermectin, covid-19, BDI, viral RNA", "why": "to figure out effective and reliable ways of reducing covid cells and cases"}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_24", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-26 16:43:54", "close_timestamp": 1637945034849, "created": "26/11/2021 16:43:47", "department": "Occupational Psychology", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-26", "gender": "female", "id": "289a902e-376a-4fb8-9292-e8fb0c1b19fb", "open_date_time": "2021-10-26 16:34:34", "open_timestamp": 1637944474668, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "Novavax vaccine faces challenges in USA, such as effectiveness against Covid-19 and global strains..", "task_condition": "viz", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 560181, "what": "the challenges the Novavax vaccine will have if taken in the USA", "when_happened": "few_month_ago", "where_location": "United states of America", "who": "Novavax vaccine, USA, covid-19", "why": "Gives a risk assessment of the vaccine and how it will effect USA, other countries, supply issues and rate of success"}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_24", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-26 16:32:36", "close_timestamp": 1637944356216, "created": "26/11/2021 16:32:28", "department": "Occupational Psychology", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-26", "gender": "female", "id": "9a1c1a25-f6d4-4958-bec5-0a1be89a4412", "open_date_time": "2021-10-26 16:25:43", "open_timestamp": 1637943943422, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "Triple antibiotic therapy could end the pandemic in two months if GPs are allowed to offer the drugs", "task_condition": "text", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 412794, "what": "to allow GPs to give out/use ivermectin as treatments as a triple antibiotic therapy for covid", "when_happened": "few_years_ago", "where_location": "australia", "who": "Thomas Borody, Ivermectin, covid-19", "why": "theorises that allowing the treatment will be able to end the pandemic in two months in australia"}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_24", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-26 16:52:40", "close_timestamp": 1637945560277, "created": "26/11/2021 16:52:32", "department": "Occupational Psychology", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-26", "gender": "female", "id": "848c7eb1-400b-4731-8c3d-a2967d1c0196", "open_date_time": "2021-10-26 16:44:3", "open_timestamp": 1637945043857, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "Japan is the first country to approve Ronapreve to treat covid-19 infections. The approval was granted on 21/07/2020. Was found to be effective in reducing infections and looked at the delta strain too.", "task_condition": "viz", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 516420, "what": "Japan being the first to approve Ronapreve as a way to treat covid-19", "when_happened": "few_years_ago", "where_location": "Japan", "who": "Japan, Ronapreve, covid-19, Dr Osamu Okuda", "why": "explains why and how Japan approved Ronapreve and it's effect on covid-19"}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_24", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-26 17:6:24", "close_timestamp": 1637946384303, "created": "26/11/2021 17:06:16", "department": "Occupational Psychology", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-26", "gender": "female", "id": "99adaf75-ae54-45be-820d-14742c457494", "open_date_time": "2021-10-26 16:52:52", "open_timestamp": 1637945572720, "summary": "The Pfizer vaccine has been shown to be effective against covid-19 infections and has been suggested to be effective against the Indian strain. According to Public Health England (PHE), it reduces number of hospitalisation and death as it has a higher rate of protection. The Pfizer vaccine had a 88% protection rate against the Indian strain, compared to the AstraZeneca vaccine, which had only 60%, after two weeks. According to PHE, they predict that the Pfizer vaccine prevented over 13,000 deaths in older people. The vaccine has also has extended its shelf-life, from 5 to 31 days. The extended storage life was approved around 21/05/2021. The was a time limit on when vaccines had to be used by were due to storing it but now the vaccine can be stored in normal fridges and last longer, allowing more patients to have it available. ", "task_condition": "text", "task_key": "pfizer", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 811583}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_24", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-26 17:23:39", "close_timestamp": 1637947419314, "created": "26/11/2021 17:23:31", "department": "Occupational Psychology", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-26", "gender": "female", "id": "dd17dec1-d321-4dd7-9af4-ec1c1e518110", "open_date_time": "2021-10-26 17:6:44", "open_timestamp": 1637946404536, "summary": "The AstraZeneca (LSE: AZN) vaccine was developed by the UK quite late from other vaccines against covid-19. It has issues with shipping and the European Union (EU) was prepared to the sue the UK developers for its failing supplies. The lack of vaccines was violating the contract between the UK and EU as cases were rising. There had been manufacturing delays which is why the supplies were slow and limited but the reliability of the trade was being questioned by EU members. However, the US were willing to donate vaccines. They would donate up to 60 million doses of Vaxzevria worldwide. But the US were not using that vaccine, nor was is approved, yet global leaders asked for the release of the supplies.\r\nAlthough the AstraZeneca vaccine is effective, it has been found to cause blood clots in some patients. 79 people had blood clots, with 19 dying. A review by the Medicines and Healthcare products Regulatory Agency (MHRA) was conducted and concluded that the criteria to receive the vaccine would change but stated that if people had already had the first vaccine, they should get the second if there was no blood clot complications. ", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 1014778}}}